One thing admirable here is the management. Consistent conservative stance on their own business and clear focus on specialty APIs and CSM. This is so unlike Laurus where I get lost with what management wants to convey. They are diversifying into animal health, crop science what not with debt laden balance sheet. Neuland management knows they can deliver 15% topline growth over 3-5 years with margin expansion without spreading legs into multiple segments.
PS: They even took a dig at Laurus by saying their focus is the differentiator and don’t want to do agro or animal health.
Disc: Invested here and maybe biased due to differential in recent price performance of Laurus and Neuland
| Subscribe To Our Free Newsletter |
